1. Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Issue 6 (22nd June 2019) Authors: Visvanathan, Sudha; Daniluk, Stefan; Ptaszyński, Rafał; Müller-Ladner, Ulf; Ramanujam, Meera; Rosenstock, Bernd; Eleftheraki, Anastasia G; Vinisko, Richard; Petříková, Alena; Kellner, Herbert; Dokoupilova, Eva; Kwiatkowska, Brygida; Alten, Rieke; Schwabe, Christian; Baum, Patrick; Joseph, David; ... Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 6(2019) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Issue 6 (22nd March 2019) Authors: Visvanathan, Sudha; Daniluk, Stefan; Ptaszyński, Rafał; Müller-Ladner, Ulf; Ramanujam, Meera; Rosenstock, Bernd; Eleftheraki, Anastasia G; Vinisko, Richard; Petříková, Alena; Kellner, Herbert; Dokoupilova, Eva; Kwiatkowska, Brygida; Alten, Rieke; Schwabe, Christian; Baum, Patrick; Joseph, David; ... Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 6(2019) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study. Issue 6 (23rd June 2012) Authors: Genovese, Mark C; Durez, Patrick; Richards, Hanno B; Supronik, Jerzy; Dokoupilova, Eva; Mazurov, Vadim; Aelion, Jacob A; Lee, Sang-Heon; Codding, Christine E; Kellner, Herbert; Ikawa, Takashi; Hugot, Sophie; Mpofu, Shephard Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 6(2013) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0075 SYSTEMATIC ANALYSIS OF INJECTION-SITE PAIN CAUSED BY SUBCUTANEOUS ADMINISTRATION OF THE ADALIMUMAB BIOSIMILAR FKB327 VERSUS ADMINISTRATION OF THE ADALIMUMAB REFERENCE PRODUCT VIA DIFFERENT DELIVERY METHODS. (June 2019) Authors: Alten, Rieke; Genovese, Mark C.; Boyce, Malcolm; Yonemura, Takuma; Ito, Takahiro; Kellner, Herbert Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study. (November 2014) Authors: Fleischmann, Roy; Goldman, John A.; Leirisalo-Repo, Marjatta; Zanetakis, Ellen; El-Kadi, Hisham; Kellner, Herbert; Bolce, Rebecca; DeHoratius, Raphael; Wang, Jim; Decktor, Dennis Journal: Current medical research and opinion Issue: Volume 30:Number 11(2014:Nov.) Page Start: 2139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study. Issue 2 (6th August 2015) Authors: Baraliakos, Xenofon; Borah, Babul; Braun, Juergen; Baeten, Dominique; Laurent, Didier; Sieper, Joachim; Emery, Paul; McInnes, Iain B; van Laar, Jacob M; Wordsworth, Paul; Wollenhaupt, Juergen; Kellner, Herbert; Colin, Laurence; Vandenhende, Francois; Radford, Kath; Hueber, Wolfgang Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 2(2016) Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies. Issue 1 (5th May 2020) Authors: Genovese, Mark C; Kellner, Herbert; Arai, Yasumasa; Muniz, Rafael; Alten, Rieke Journal: RMD open Issue: Volume 6:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial. (January 2023) Authors: Koehm, Michaela; Rossmanith, Tanja; Foldenauer, Ann C; Herrmann, Eva; Brandt-Jürgens, Jan; Burmester, Gerd R; Kellner, Herbert; Kiltz, Uta; Kofler, David M; Rech, Jürgen; Mojtahed-Poor, Sorwe; Jonetzko, Christin; Burkhardt, Harald; Behrens, Frank; Alten, Rieke H.E.; Benesova, Karolina; Bergner, R... Journal: Lancet Issue: Volume 5:Number 1(2023) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study). (5th March 2021) Authors: Behrens, Frank; Koehm, Michaela; Rossmanith, Tanja; Alten, Rieke; Aringer, Martin; Backhaus, Marina; Burmester, Gerd R; Feist, Eugen; Herrmann, Eva; Kellner, Herbert; Krueger, Klaus; Lehn, Annette; Müller-Ladner, Ulf; Rubbert-Roth, Andrea; Tony, Hans-Peter; Wassenberg, Siegfried; Burkhardt, Harald Journal: Rheumatology Issue: Volume 60:Number 11(2021) Page Start: 5318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0132 LONG-TERM SAFETY, IMMUNOGENICITY AND EFFICACY IN RANDOMIZED, DOUBLE-BLIND, AND OPEN-LABEL EXTENSION STUDIES COMPARING FKB327, AN ADALIMUMAB BIOSIMILAR, WITH THE ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. (June 2019) Authors: Alten, Rieke; Genovese, Mark C.; Muniz, Rafael; Kellner, Herbert Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗